about
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical ...
Read More
1.18
0.07
(6.31%)
464.2K
XNAS Volume
XNAS 07 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for MaxCyte Inc is on 12 Aug 2026 for the purpose of MaxCyte Inc Second Quarter Earnings Result for 2026
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
MaxCyte Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..